| KARO BIO AB Patent applications |
| Patent application number | Title | Published |
|---|
| 20130131061 | Novel Estrogen Receptor Ligands - The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, and a solvate of such an ester, amide, carbamate or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity, wherein R | 05-23-2013 |
| 20120202861 | NOVEL ESTROGEN RECEPTOR LIGANDS - The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity. Formula (I) wherein R | 08-09-2012 |
| 20120202853 | SUBSTITUTED PYRAZOLES AS ESTROGEN RECEPTOR LIGANDS - The invention provides a compound of formula (I) wherein G is a pyrazole ring as defined in the specification and R | 08-09-2012 |
| 20100004271 | HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR - The invention provides Compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, wherein R | 01-07-2010 |
| 20080221210 | Thyroid Receptor Agonists - The invention provides compounds of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition mediated by a thyroid receptor. Formula (I), wherein R | 09-11-2008 |
